June 29, 2011 — A new study utilizing data from the Intersocietal Commission for the Accreditation of Nuclear Medicine Laboratories (ICANL) suggests that while noncompliance with reporting standards is found in the majority of nuclear cardiology laboratories throughout the U.S., those facilities participating in the ICANL accreditation process demonstrate an increase in compliance over time.

June 29, 2011 – The University of Chicago is allowing Pinnacle Oncology to acquire its technology and intellectual property rights for the development of a compound, amifostine, to prevent genomic instability caused by a variety of sources of ionizing radiation exposure, including common computed tomography (CT) scans.

June 29, 2011 –The U.S. Food and Drug Administration (FDA) has given 510(k) market clearance of the 30-inch MultiSync MD301C4 medical diagnostic display for the displaying and viewing of digital images for diagnosis by trained physicians. The display is made by NEC Display Solutions of America.

June 29, 2011 – The experimental antiplatelet drug ticagrelor prevented significantly more cardiovascular complications than the standard medication clopidogrel when used with low-dose aspirin, according to new research reported in the American Heart Association's Emerging Science Series webinar.


Probably the biggest trend occurring in cardiovascular ultrasound systems today is the adoption of 3-D/4-D echo systems, which offer the benefits of better images, more data, better measurement quantification and faster workflow. Other key trends include: software to speed workflow with fewer keystrokes and to enhance quantification; miniaturization; increased use of tissue strain imaging, and expanded use for operating room and cath lab procedures.

June 29, 2011 – To expand manufacturing operations and commercial infrastructure to support growing demand for the LipiScan IVUS (intravascular ultrasound) Coronary Imaging System, InfraReDx Inc. announced it raised $24.1 million from the sale of equity to existing InfraReDx shareholders.

June 29, 2011 – An industry-first collaboration is bringing together cardiovascular testing company Atherotech Diagnostics Lab and diabetes testing company GlycoMark. The collaboration means the two companies will jointly commercialize the VAP (vertical auto profile) cholesterol test with the GlycoMark diabetes test.

June 29, 2011 – For the first time, human blood vessels grown in a laboratory from donor skin cells have been successfully implanted into patients, according to new research presented in the American Heart Association (AHA)’s Emerging Science Series webinar.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now